37 / 76
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 2, March/April 2017
AFRICA
103
9.
Barrabés JA, Figueras J, Moure C, Cortadellas J, Soler-Soler J.
Prognostic value of lead aVR in patients with a first non-ST-segment
elevation acute myocardial infarction.
Circulation
2003;
108
: 814–819.
10. Rostoff P, Piwowarska W. ST segment elevation in lead aVR and coro-
nary artery lesions in patients with acute coronary syndrome.
Kardiol
Pol
2006;
64
: 8–14.
11. Schechtman KB, Capone RJ, Kleiger RE, Gibson RS, Schwartz DJ,
Roberts R,
et al
. Risk stratification of patients with non-Q-wave
myocardial infarction. The critical role of ST segment depression. The
Diltiazem Reinfarction Study Research Group.
Circulation
1989;
80
:
1148–1158.
12. Cannon CP, McCabe CH, Stone PH, Rogers WJ, Schactman M,
Thompson BW,
et al
. The electrocardiogram predicts one-year outcome
of patients with unstable angina and non-Q wave myocardial infarction:
results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in
Myocardial Ischemia.
J Am Coll Cardiol
1997;
30
: 133–140.
13. Hasdai D, Sclarovsky S, Solodky A, Sulkes J, Strasberg B, Birnbaum Y.
Prognostic significance of maximal precordial ST-segment depression in
right (V1 to V3) versus left (V4 to V6) leads in patients with inferior wall
acute myocardial infarction.
Am J Cardiol
1994;
74
: 1081–1084.
14. Pride YB, Tung P, Mohanavelu S, Zorkun C, Wiviott SD, Antman
EM,
et al
; TIMI Study Group. Angiographic and clinical outcomes
among patients with acute coronary syndromes presenting with isolat-
ed anterior ST-segment depression: a TRITON-TIMI 38 (Trial to
Assess Improvement in Therapeutic Outcomes by Optimizing Platelet
Inhibition With Prasugrel) substudy.
J Am Coll Cardiol Cardiovasc
Interv
2010;
3
: 806–811.
15. Zhao Y, Wang J, Huang G, Ding C. Significance of ST-segment eleva-
tion in lead aVR.
Chin Med J
(Engl) 2014;
127
(16): 3034.
16. Taglieri N, Marzocchi A, Saia F, Marrozzini C, Palmerini T, Ortolani
P
et al
. Short- and long-term prognostic significance of ST-segment
elevation in lead aVR in patients with non-ST-segment elevation acute
coronary syndrome.
Am J Cardiol
2011;
108
: 21–28.
17. Crijns HJ, van Gelder IC, van Gilst WH, Hillege H, Gosselink AM, Lie
KI. Serial antiarrhythmic drug treatment to maintain sinus rhythm after
electrical cardioversion for chronic atrial fibrillation or atrial flutter.
Am
J Cardiol
1991;
68
: 335–341.
18. Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den
Brand MJ,
et al
; ARTS II. Cyphering the complexity of coronary artery
disease using the SYNTAX score to predict clinical outcome in patients
with three-vessel lumen obstruction undergoing percutaneous coronary
intervention.
Am J Cardiol
2007;
99
: 1072–1081.
19. Nabati M, Emadi M, Mollaalipour M, Bagheri B, Nouraei M.
ST-segment elevation in lead aVR in the setting of acute coro-
nary syndrome.
Acta Cardiol
2016;
71
(1): 47–54. doi: 10.2143/
AC.71.1.3132097.
20. Misumida N, Kobayashi A, Fox JT, Hanon S, Schweitzer P, Kanei Y.
Predictive value of ST-segment elevation in lead aVR for left main and/
or three-vessel disease in non-ST-segment elevation myocardial infarc-
tion.
Ann Noninvasive Electrocardiol
2016;
21
: 91–97. doi: 10.1111/
anec.12272.
21. Nabati M, Emadi M, Mollaalipour M, Bagheri B, Nouraei M.
ST-segment elevation in lead aVR in the setting of acute coronary
syndrome.
Acta Cardiol
2016;
71
: 47–54. doi: 10.2143/AC.71.1.3132097.
Matie cardiologist receives prestigious fellowship
FMHS Marketing & Communication/FGGW Bemarking & Kommunikasie
A senior registrar from the Division of Cardiology, Dr Marshall
Heradien, was awarded the prestigious Hamilton Naki Clinical
Scholarship for 2016.
He was one of two researchers to receive the award last year.
Dr Shrish Budree, a paediatric gastroenterologist currently
studying at Harvard University, is the other recipient.
“This scholarship initiative, in which Netcare has joined hands
with the medical schools of South African universities, creates
opportunities for deserving South African medical practitioners
to further their studies and research in their respective fields of
specialisation, before returning to South Africa to continue to
contribute towards the advancement of South African academic
medicine,”Dr Richard Friedland, chief executive of Netcare said
at the awards ceremony according to a statement by Netcare.
The award is named after Hamilton Naki, a self-taught surgeon
who assisted in the experimental work that preceded the first
human heart transplant. Naki was recognised by the legendary
Prof Christiaan Barnard as a man of extraordinary natural surgical
ability, but who, due to the policies of apartheid, was denied any
formal medical training, despite his remarkable aptitude.
“In this way, we honour the legacy of Hamilton Naki and
numerous other South Africans who were denied the chance to
fulfil their potential in the field of medicine during apartheid
and ensure the continued progress of medicine in our country,”
said Friedland.
Dr Bonginkosi Chiliza, who until recently was an associate
professor at the Department of Psychiatry, is the only other
Matie to receive the award in the almost 10 years of its existence.
Published with permission by the University of Stellenbosch: Faculty of Medicine
& Health Sciences Marketing & Communication
Prof Bongani Mayosi, Dean of the Faculty of Health Sciences of
the University of CapeTown, Dr Marshall Heradien, a cardiologist
and specialist physician at Stellenbosch University who is one
of the recipients of the 2016 Hamilton Naki Clinical Scholarship,
and Dr Richard Friedland, chief executive officer of Netcare.